Humana Inc. (LON:0J6Z)
London · Delayed Price · Currency is GBP · Price in USD 179.52
+1.52 (0.85%)
At close: Feb 12, 2026
Humana Employees
Humana had 65,680 employees as of December 31, 2024. The number of employees decreased by 1,920 or -2.84% compared to the previous year.
Employees
65,680
Change (1Y)
-1,920
Growth (1Y)
-2.84%
Revenue / Employee
1.47M GBP
Profits / Employee
13.44K GBP
Market Cap
15.50B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 65,680 | -1,920 | -2.84% |
| Dec 31, 2023 | 67,600 | 500 | 0.75% |
| Dec 31, 2022 | 67,100 | -28,400 | -29.74% |
| Dec 31, 2021 | 95,500 | 46,800 | 96.10% |
| Dec 31, 2020 | 48,700 | 2,700 | 5.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,000 |
| Convatec Group | 10,000 |
| Hikma Pharmaceuticals | 9,500 |
| CVS Group | 8,850 |
| Genus | 3,190 |
Humana News
- 10 days ago - Humana declines as Morgan Stanley downgrades over Medicare Advantage concerns - Seeking Alpha
- 10 days ago - Cramer's Mad Dash: Humana - CNBC
- 10 days ago - Humana (HUM) Faces Downgrade Amid Medicare Rate Challenges - GuruFocus
- 11 days ago - Krilogy Financial LLC Buys 395 Shares of Humana Inc (HUM) - GuruFocus
- 11 days ago - Belpointe Asset Management LLC Buys 788 Shares of Humana Inc (HUM) - GuruFocus
- 13 days ago - TOKIO MARINE ASSET MANAGEMENT CO LTD Buys 242 Shares of Humana Inc (HUM) - GuruFocus
- 13 days ago - REGIONS FINANCIAL CORP Sells 1,041 Shares of Humana Inc (HUM) - GuruFocus
- 13 days ago - UnitedHealth Rival Humana Tops Valuation Metric As 26% YTD Plunge Creates Entry Point Amid Trump's Proposed Medicare Rates - Benzinga